Clinical Trial

Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB1,IB2,IIA1)

Study acronym: LAUNCH 2
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 1, 2021 (before its estimated September 7, 2024 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to confirm whether there is a difference between laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) in patient survival for Cervical Cancer (Stage IB1, IB2, IIA1).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-06-10.
Trial Details
NCT Number NCT04929769
Lead Sponsor Obstetrics & Gynecology Hospital of Fudan University
Collaborators: Children's Hospital of Fudan University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Zhongshan Hospital, RenJi Hospital, Taizhou Hospital, Affiliated Cancer Hospital of the University of Chinese Academy of Sciences, First Affiliated Hospital of Wenzhou Medical University
Conditions Cervical Cancer
Enrollment 780 participants
Start Date 2021-05-07
Primary Completion 2024-09-07 (estimated)
Study Completion 2026-09-07 (estimated)
Updated on ClinicalTrials.gov 2021-11-01